Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations

References

• World Health Immunization (WHO). Vaccines and immunization; 2013 [accessed 2021 April 7]. https://www.who.int/health-topics/vaccines-and-immunization#tab=tab_1 .
   Google Scholar
• Napolitano F, Della Polla G, Capano MS, Augimeri M, Angelillo IF. Vaccinations and chronic diseases: knowledge, attitudes, and self-reported adherence among patients in Italy. Vaccines (Basel). 2020;25(8):560. doi:10.3390/vaccines8040560.
   Google Scholar
• Doherty M, Schmidt-Ott R, Santos JI, Stanberry LR, Hofstetter AM, Rosenthal SL, Cunningham AL. Vaccination of special populations: protecting the vulnerable. Vaccine. 2016;34:6681–90. doi:10.1016/j.vaccine.2016.11.015.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Adults with health conditions; 2017 [accessed 2021 April 7]. https://www.cdc.gov/features/vaccineschronicconditions/index.html.
   Google Scholar
• Doherty TM, Connolly MP, Del Giudice G, Flamaing J, Goronzy JJ, Grubeck-Loebenstein B, Lambert PH, Maggi S, McElhaney JE, Nagai H, et al. Vaccination programs for older adults in an era of demographic change. Eur Geriatr Med. 2018;9:289–300. doi:10.1007/s41999-018-0040-8.
   PubMed Web of Science ®Google Scholar
• Burke M, Rowe T. Vaccinations in older adults. Clin Geriatr Med. 2018;34(1):131–43. doi:10.1016/j.cger.2017.08.006.
   PubMed Web of Science ®Google Scholar
• Coll PP, Costello VW, Kuchel GA, Bartley J, McElhaney JE. The prevention of infections in older adults: vaccination. J Am Geriatr Soc. 2020;68:207–14. doi:10.1111/jgs.16205.
   PubMed Web of Science ®Google Scholar
• Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244–54.
   PubMed Web of Science ®Google Scholar
• Shaw AC, Goldstein DR, Montgomery RR. Age-dependent dysregulation of innate immunity. Nat Rev Immunol. 2013;13:875–87. doi:10.1038/nri3547.
   PubMed Web of Science ®Google Scholar
• Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol. 2004;5:133–39. doi:10.1038/ni1033.
   PubMed Web of Science ®Google Scholar
• Weinberger B. Vaccines for the elderly: current use and future challenges. Immun Ageing. 2018;15(22):3. doi:10.1186/s12979-017-0107-2.
   PubMedGoogle Scholar
• Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the advisory committee on immunization practices (ACIP) and recommendation of ACIP, supported by the healthcare infection control practices advisory committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep. 2006;15:1–37.
   Google Scholar
• Lecrenier N, Beukelaers P, Colindres R, Curran D, De Kesel C, De Saegher JP, Didierlaurent AM, Ledent EY, Mols JF, Mrkvan T, et al. Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention. Expert Rev Vaccines. 2018;17:619–34. doi:10.1080/14760584.2018.1495565.
   PubMed Web of Science ®Google Scholar
• McGirr A, Widenmaier R, Curran D, Espié E, Mrkvan T, Oostvogels L, Simone B, McElhaney JE, Burnett H, Haeussler K, et al. The comparative efficacy and safety of herpes zoster vaccines: a network meta-analysis. Vaccine. 2019;16:2896–909. doi:10.1016/j.vaccine.2019.04.014.
   Google Scholar
• Dooling KL, Guo A, Patel M, Lee GM, Moore K, Belongia EA, Harpaz R. Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines. Morbidity Mortality Weekly Report US, CDC. 2018;26:103–08. doi:10.15585/mmwr.mm6703a5.
   Google Scholar
• Warrington R, Ismail S. National Advisory Committee on Immunization (NACI). Summary of the NACI update on Herpes Zoster vaccines. Can Commun Dis Rep. 2018;6:220–25. doi:10.14745/ccdr.v44i09a06.
   Google Scholar
• Siedler A, Koch J, Garbe E, Hengel H, von Kries R, Ledig T, Mertens T, Zepp F, Überla K. Background paper to the decision to recommend the vaccination with the inactivated herpes zoster subunit vaccine: statement of the German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019;62:352–76. doi:10.1007/s00103-019-02882-5.
   PubMed Web of Science ®Google Scholar
• Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020;395:1225–28. doi:10.1016/S0140-6736(20)30627-9.
   PubMed Web of Science ®Google Scholar
• Center for Disease Control and Prevention. Recommended adult immunization schedule for ages 19 years or older, United States; 2021 [accessed 2021 April 7]. https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html.
   Google Scholar
• European Centre for Disease Prevention and Control; 2021 [accessed 2021 April 7]. https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=15&SelectedCountryIdByDisease=1.
   Google Scholar
• Italian National Health System (ISS). Calendario vaccinale [accessed 2021 April 7]. https://www.epicentro.iss.it/vaccini/calendario.
   Google Scholar
• National Health Service (UK). NHS vaccinations and when to have them [accessed 2021 April 7]. https://www.nhs.uk/conditions/vaccinations/nhs-vaccinations-and-when-to-have-them/.
   Google Scholar
• National Advisory Committee on Immunization (NACI). Statements and publications [accessed 2021 April 7]. https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci.html.
   Google Scholar
• Statement of the German standing committee on vaccination at the RKI recommendations of the standing committee on vaccination (STIKO) at the Robert Koch Institute – 2017/2018 [accessed 2021 April 7]. https://www.rki.de/EN/Content/infections/Vaccination/recommandations/recommendations_node.html.
   Google Scholar
• European Centre for Disease Prevention and Control [accessed 2021 April 7]. https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=−1.
   Google Scholar
• European Centre for Disease Prevention and Control. [accessed 2021 April 7]. https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=3&SelectedCountryIdByDisease=−1.
   Google Scholar
• European Centre for Disease Prevention and Control. [accessed 2021 April 7]. https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=51&SelectedCountryIdByDisease=−1.
   Google Scholar
• Center for Disease Control and Prevention. COVID-19 ACIP vaccine recommendations. [accessed 2021 April 7]. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html.
   Google Scholar
• European Centre for Disease Prevention and Control. High-risk groups for COVID-19. [accessed 2021 April 7]. https://www.ecdc.europa.eu/en/covid-19/high-risk-groups.
   Google Scholar
• Italian National Health System (ISS). Raccomandazioni ad interim sui gruppi target della vaccinazione anti SARS-CoV-2/COVID-19 [accessed 2021 April 13]. https://www.epicentro.iss.it/vaccini/covid-19-piano-vaccinazione.
   Google Scholar
• National Health Service (UK). Coronavirus (COVID-19) vaccine [accessed 2021 April 13]. https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/coronavirus-vaccine/.
   Google Scholar
• McElhaney JE, Kuchel GA, Zhou X, Swain SL, Haynes L. T-cell immunity to influenza in older adults: a pathophysiological framework for development of more effective vaccines. Front Immunol. 2016;7:41.
   PubMed Web of Science ®Google Scholar
• Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis. 2003;188:1336. doi:10.1086/379048.
   PubMed Web of Science ®Google Scholar
• Kang JH, Ho JD, Chen YH, Lin HC. Increased risk of stroke after a herpes zoster attack. Stroke. 2009;40:3443–48. doi:10.1161/STROKEAHA.109.562017.
   PubMed Web of Science ®Google Scholar
• Kandeil W, Atanasov P, Avramioti D, Fu J, Demarteau N, Li X. The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review. Expert Rev Vaccines. 2019;18:439–55. doi:10.1080/14760584.2019.1588727.
   PubMed Web of Science ®Google Scholar
• Hung IFN, Leung AYM, Chu DWS, Leung D, Cheung T, Chan C, Lam CLK, Liu S, Chu C, Ho P, et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis. 2010;51:1007–16. doi:10.1086/656587.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Cardiovascular disease; 2020 [accessed 2021 April 13]. https://www.who.int/health-topics/cardiovascular-diseases/#tab=tab_1.
   Google Scholar
• Fountoulaki K, Tsiodras S, Polyzogopoulou E, Olympios C, Parissis J. Beneficial effects of vaccination on cardiovascular events: myocardial infarction, stroke, heart failure. Cardiology. 2018;141:98–106. doi:10.1159/000493572.
   PubMed Web of Science ®Google Scholar
• Brown AO, Millett ERC, Quint JK, Orihuela CJ. Cardiotoxicity during invasive pneumococcal disease. Am J Respir Crit Care Med. 2015;191:739–45. doi:10.1164/rccm.201411-1951PP.
   PubMed Web of Science ®Google Scholar
• Marra F, Zhang A, Gillman E, Bessai K, Parhar K, Vadlamudi NK. The protective effect of pneumococcal vaccination on cardiovascular disease in adults: a systematic review and meta-analysis. Int J Infect Dis. 2020;99:204–13. doi:10.1016/j.ijid.2020.07.038.
   PubMed Web of Science ®Google Scholar
• Liu C, Yavar Z, Sun Q. Cardiovascular response to thermoregulatory challenges. Am J Physiol Heart Circ Physiol. 2015;309:1793–812. doi:10.1152/ajpheart.00199.2015.
   PubMed Web of Science ®Google Scholar
• Vardeny O, Solomon SD. Influenza vaccination: a one-shot deal to reduce cardiovascular events. Eur Heart J. 2017;38:334–37.
   PubMed Web of Science ®Google Scholar
• Musher DM, Rueda AM, Kaka AS, Mapara SA. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis. 2007;45:158–65. doi:10.1086/518849.
   PubMed Web of Science ®Google Scholar
• Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17:543–58. doi:10.1038/s41569-020-0413-9.
   PubMed Web of Science ®Google Scholar
• American College of Cardiology. ACC health policy statement on cardiovascular disease considerations for COVID-19 vaccine prioritization. J Am Coll Cardiol. 2021;77:15.
   PubMed Web of Science ®Google Scholar
• Herpes Zoster: W-GC. Epidemiological links with stroke and myocardial infarction. J Infect Dis. 2018;218:S102–S106.
   PubMed Web of Science ®Google Scholar
• Center for Disease Control and Prevention. Recommended adult immunization schedule by medical condition and other indications, United States, 2021; 2021 [accessed 2021 April 13]. https://www.cdc.gov/vaccines/schedules/hcp/imz/adult-conditions.html.
   Google Scholar
• World Health Organization. Influenza position paper. [accessed 2021 April 13]. https://www.who.int/immunization/policy/position_papers/influenza/en/.
   Google Scholar
• European Centre for Disease Prevention and Control. Expert opinion on priority risk groups for influenza vaccination. [accessed 2021 April 13]. https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/0808_GUI_Priority_Risk_Groups_for_Influenza_Vaccination.pdf.
   Google Scholar
• Italian Ministry of Health. National immunization plan 2017-2019 [accessed 2021 April 13]. http://www.gazzettaufficiale.it/eli/id/2017/02/18/17A01195/sg.
   Google Scholar
• Australian Government Department of Health. Pneumococcal vaccination for people with risk conditions for pneumococcal disease [accessed 2021 April 13]. https://immunisationhandbook.health.gov.au/resources/publications/pneumococcal-vaccination-for-people-with-risk-conditions-for-pneumococcal.
   Google Scholar
• National Health Service (UK). Who is at high risk from coronavirus (clinically extremely vulnerable). Who is at high risk from coronavirus (clinically extremely vulnerable) – NHS [accessed 2021 April 13]. www.nhs.uk.
   Google Scholar
• Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, Fadel SA, Tran D, Fernandez E, Bhatnagar N, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;23:47–f5061.
   Google Scholar
• Gurfinkel EP, de la Fuente RL. Two-year follow-up of the FLU vaccination acute coronary syndromes (FLUVACS) registry. Texas Heart Inst J. 2004;31:28–32.
   PubMed Web of Science ®Google Scholar
• Macintyre CR, Heywood AE, Kovoor P, Ridda I, Seale H, Tan T, Gao Z, Katelaris AL, Siu HW, Lo V, et al. Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study. Heart. 2013;99:1843–48. doi:10.1136/heartjnl-2013-304320.
   PubMed Web of Science ®Google Scholar
• Siriwardena AN, Gwini SM, Coupland CA. Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study. CMAJ. 2010;19:1617–23. doi:10.1503/cmaj.091891.
   Google Scholar
• Johnstone J, Loeb M, Teo KK, Gao P, Dyal L, Liu L, Avezum A, Cardona-Munoz E, Sleight P, Fagard R, et al. Influenza vaccination and major adverse vascular events in high-risk patients. Circulation. 2012;17:278–86. doi:10.1161/CIRCULATIONAHA.111.071100.
   Google Scholar
• Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. 2015;5:CD005050.
   Google Scholar
• Torres A, Blasi F, Dartois N, Akova M. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax. 2015;70:984–89. doi:10.1136/thoraxjnl-2015-206780.
   PubMed Web of Science ®Google Scholar
• Britto CJ, Brady V, Lee S, Dela Cruz CS. Respiratory viral infections in chronic lung diseases. Clin Chest Med. 2017;38:87–96. doi:10.1016/j.ccm.2016.11.014.
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare. Vaccination uptake among people with chronic respiratory disease [accessed 2021 April 13]. https://www.aihw.gov.au/reports/chronic-respiratory-conditions/vaccination-uptake-among-people-with-chronic-respi/contents/table-of-contents.
   Google Scholar
• Conway SP, Simmonds EJ, Littlewood JM. Acute severe deterioration in cystic fibrosis associated with influenza A virus infection. Thorax. 1992;47:112–14. doi:10.1136/thx.47.2.112.
   PubMed Web of Science ®Google Scholar
• Pribble CG, Black PG, Bosso JA, Turner RB. Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections. J Pediatr. 1990;117:200–04. doi:10.1016/S0022-3476(05)80530-X.
   PubMed Web of Science ®Google Scholar
• Ortiz JR, Neuzil KM, Victor JC, Wald A, Aitken ML, Goss CH. Influenza-associated cystic fibrosis pulmonary exacerbations. Chest. 2010;137:852–60. doi:10.1378/chest.09-1374.
   PubMed Web of Science ®Google Scholar
• Blasi F, Bonanni P, Braido F, Gabutti G, Marchetti F, Centanni S. The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context. Hum Vaccin Immunother. 2020;16:340–48. doi:10.1080/21645515.2019.1652517.
   PubMed Web of Science ®Google Scholar
• Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhou Y. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95. doi:10.1016/j.ijid.2020.03.017.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. 2020 Global strategy for prevention, diagnosis and management of COPD. [accessed 2021 May 4]. https://goldcopd.org/gold-reports/.
   Google Scholar
• Global Initiative for Asthma (GINA). 2021 GINA report, global strategy for asthma management and prevention. [accessed 2021 May 4]. https://ginasthma.org/gina-reports/.
   Google Scholar
• Wark PA, Gibson PG. Asthma exacerbations. 3: pathogenesis. Thorax. 2006;61:909–15. doi:10.1136/thx.2005.045187.
   PubMed Web of Science ®Google Scholar
• Papadopoulos NG, Christodoulou I, Rohde G, Agache I, Almqvist C, Bruno A, Bonini S, Bont L, Bossios A, Bousquet J, et al. Viruses and bacteria in acute asthma exacerbations–a GA2 LEN-DARE systematic review. Allergy. 2011;66:458–68. doi:10.1111/j.1398-9995.2010.02505.x.
   PubMed Web of Science ®Google Scholar
• Gerke AK, Yang M, Tang F, Foster ED, Cavanaugh JE, Polgreen PM. Association of hospitalizations for asthma with seasonal and pandemic influenza. Respirology. 2014;19:116–21. doi:10.1111/resp.12165.
   PubMed Web of Science ®Google Scholar
• Goldstein E, Viboud C, Charu V, Lipsitch M. Improving the estimation of influenza-related mortality over a seasonal baseline. Epidemiology. 2012;23:829–38. doi:10.1097/EDE.0b013e31826c2dda.
   PubMedGoogle Scholar
• Nichol KL. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine. 2003;21:1769–75. doi:10.1016/S0264-410X(03)00070-7.
   PubMed Web of Science ®Google Scholar
• Kramarz P, Destefano F, Gargiullo PM, Chen RT, Lieu TA, Davis RL, Mullooly JP, Black SB, Shinefield HR, Bohlke K, et al. Vaccine safety datalink team does influenza vaccination prevent asthma exacerbations in children?. J Pediatr. 2001;138:306–10.
   PubMed Web of Science ®Google Scholar
• Smits AJ, Hak E, Stalman WA, Van Essen GA, Hoes AW, Verheij TJ. Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol Infect. 2002;128:205–11. doi:10.1017/S0950268801006574.
   PubMed Web of Science ®Google Scholar
• Ong BA, Forester J, Fallot A. Does influenza vaccination improve pediatric asthma outcomes? J Asthma. 2009;46:477–80. doi:10.1080/02770900902795538.
   PubMed Web of Science ®Google Scholar
• Hak E, Buskens E, Van Essen GA, de Bakker DH, Grobbee DE, Tacken MA, van Hout BA, Verheij TJ. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med. 2005;14:274–80. doi:10.1001/archinte.165.3.274.
   Google Scholar
• Poole PJ, Chacko E, Wood-Baker RW, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;25:CD002733.
   Google Scholar
• Sung LC, Chen CI, Fang YA, Lai CH, Hsu YP, Cheng TH, Miser JS, Liu JC. Influenza vaccination reduces hospitalization for acute coronary syndrome in elderly patients with chronic obstructive pulmonary disease: a population-based cohort study. Vaccine. 2014;24:3843–49. doi:10.1016/j.vaccine.2014.04.064.
   Google Scholar
• Bornheimer R, Shea KM, Sato R, Weycker D, Pelton SI. Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease. PLoS One. 2017;13:12.
   Google Scholar
• Walters JA, Tang JN, Poole P, Wood-Baker R. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;24:CD001390.
   Google Scholar
• Tin Tin Htar M, Stuurman AL, Ferreira G, Alicino C, Bollaerts K, Paganino C, Reinert RR, Schmitt HJ, Trucchi C, Vestraeten T, et al. Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies. PLoS One. 201. 23.
   Google Scholar
• Sehatzadeh S. Influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based review. Ont Health Technol Assess Ser. 2012;12:1–64.
   Google Scholar
• Furumoto A, Ohkusa Y, Chen M, Kawakami K, Masaki H, Sueyasu Y, Iwanaga T, Aizawa H, Nagatake T, Oishi K. Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease. Vaccine. 2008;5:4284–89. doi:10.1016/j.vaccine.2008.05.037.
   Google Scholar
• Froes F, Roche N, Blasi F. Pneumococcal vaccination and chronic respiratory diseases. Int J Chron Obstruct Pulmon Dis. 2017;12:3457–68. doi:10.2147/COPD.S140378.
   PubMed Web of Science ®Google Scholar
• Lee TA, Weaver FM, Weiss KB. Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma. J Gen Intern Med. 2007;22:62–67. doi:10.1007/s11606-007-0118-3.
   PubMed Web of Science ®Google Scholar
• Ansaldi F, Turello V, Lai P, Bastone G, De Luca S, Rosselli R, Durando P, Sticchi L, Gasparini R, Delfino E, et al. Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study. J Int Med Res. 2005;33:490–500. doi:10.1177/147323000503300503.
   PubMed Web of Science ®Google Scholar
• Capili CR, Hettinger A, Rigelman-Hedberg N, Fink L, Boyce T, Lahr B, Juhn YJ. Increased risk of pertussis in patients with asthma. J Allergy Clin Immunol. 2012;129:957–63. doi:10.1016/j.jaci.2011.11.020.
   PubMed Web of Science ®Google Scholar
• Liu BC, McIntyre P, Kaldor JM, Quinn HE, Ridda I, Banks E. Pertussis in older adults: prospective study of risk factors and morbidity. Clin Infect Dis. 2012;55:1450–56. doi:10.1093/cid/cis627.
   PubMed Web of Science ®Google Scholar
• Buck PO, Meyers JL, Gordon LD, Parikh R, Kurosky SK, Davis KL. Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims. Epidemiol Infect. 2017;145:2109–21. doi:10.1017/S0950268817000887.
   PubMed Web of Science ®Google Scholar
• Aris E, Harrington L, Bhavsar A, Simeone JC, Ramond A, Papi A, Vogelmeier CF, Meszaros K, Lambrelli D, Mukherjee P. Burden of pertussis in COPD: a retrospective database study in England. COPD. 2021;18:157–69. doi:10.1080/15412555.2021.1899155.
   PubMedGoogle Scholar
• Mukherjee P, Cheuvart B, Baudson N, Dodet M, Turriani E, Harrington L, Meyer N, Rondini S, Taddei L, Den Steen PV. Late breaking abstract - Seroprevalence of Bordetella pertussis in chronic obstructive pulmonary disease (COPD) patients. Eur Respir J. 2020;56:4927.
   Web of Science ®Google Scholar
• Mbayei SA, Faulkner A, Miner C, Edge K, Cruz V, Peña SA, Kudish K, Coleman J, Pradhan E, Thomas S, et al. Severe pertussis infections in the United States, 2011–2015. Clin Infect Dis. 2019;69:218–26. doi:10.1093/cid/ciy889.
   PubMed Web of Science ®Google Scholar
• Kilgore PE, Salim AM, Zervos MJ, Schmitt HJ. Pertussis: microbiology, disease, treatment, and prevention. Clin Microbiol Rev. 2016;29:449–86.
   PubMed Web of Science ®Google Scholar
• Ennis DP, Cassidy JP, Mahon BP. Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model. Clin Diagn Lab Immunol. 2005;12:409–17.
   PubMedGoogle Scholar
• Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012;16:S27–36.
   PubMedGoogle Scholar
• Pearson-Stuttard J, Blundell S, Harris T, Cook DG, Critchley J. Diabetes and infection: assessing the association with glycaemic control in population-based studies. Lancet Diabetes Endocrinol. 2016;4:148–58. doi:10.1016/S2213-8587(15)00379-4.
   PubMed Web of Science ®Google Scholar
• Bochicchio GV, Bochicchio KM, Joshi M, Ilahi O, Scalea TM. Acute glucose elevation is highly predictive of infection and outcome in critically injured trauma patients. Ann Surg. 2010;252:597–602. doi:10.1097/SLA.0b013e3181f4e499.
   PubMed Web of Science ®Google Scholar
• Hair PS, Echague CG, Rohn RD, Krishna NK, Nyalwidhe JO, Cunnion KM. Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus. J Transl Med. 2012;10:35. doi:10.1186/1479-5876-10-35.
   PubMed Web of Science ®Google Scholar
• Goeijenbier M, van Sloten TT, Slobbe L, Mathieu C, van Genderen P, Beyer Walter EP, Osterhaus ADME. Benefits of flu vaccination for persons with diabetes mellitus: a review. Vaccine. 2017;35:5095–101. doi:10.1016/j.vaccine.2017.07.095.
   PubMed Web of Science ®Google Scholar
• Icardi G, Francia F, Di Bartolo P, Mannino D, Alti E, Purrello F, Sesti G. Multi-disciplinary Consensus Statement document vaccinal prevention in adult patients with diabetes mellitus. J Prev Med Hyg. 2018;15:E249–E256.
   Google Scholar
• Lau D, Eurich DT, Majumdar SR, Katz A, Johnson JA. Working- age adults with diabetes experience greater susceptibility to seasonal influenza: a population-based cohort study. Diabetologia. 2014;57:690–98. doi:10.1007/s00125-013-3158-8.
   PubMed Web of Science ®Google Scholar
• MacIntyre CR, Mahimbo A, Moa AM, Barnes M. Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart. 2016;102:1953–56. doi:10.1136/heartjnl-2016-309983.
   PubMed Web of Science ®Google Scholar
• Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8:782–92. doi:10.1016/S2213-8587(20)30238-2.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Diabetes Type 1 and Type 2 and adult vaccination. [accessed 2021 May 4]. https://www.cdc.gov/vaccines/adults/rec-vac/health-conditions/diabetes.html.
   Google Scholar
• Australian Government Department of Health. People with medical risk conditions. [accessed 2021 May 4]. https://www.health.gov.au/health-topics/immunisation/immunisation-throughout-life/people-with-medical-risk-conditions.
   Google Scholar
• Smith SA, Poland GA. Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care. 2000;23:95–108. doi:10.2337/diacare.23.1.95.
   PubMed Web of Science ®Google Scholar
• Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, Nelson NP. Prevention of Hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices. MMWR. Recommendations Reports. 2018;67:1–31.
   PubMed Web of Science ®Google Scholar
• Reilly ML, Schillie SF, Smith E, Poissant T, Vonderwahl CW, Gerard K, Baumgartner J, Mercedes L, Sweet K, Muleta D, et al. Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitus. J Diabetes Sci Technol. 2012;1(6):858–66. doi:10.1177/193229681200600417.
   Google Scholar
• van Veen K, Brouwer M, van der Ende A. Bacterial meningitis in diabetes patients: a population-based prospective study. Sci Rep. 2016;6:36996. doi:10.1038/srep36996.
   PubMed Web of Science ®Google Scholar
• Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151–71. doi:10.1016/j.jhep.2018.09.014.
   PubMed Web of Science ®Google Scholar
• Härmälä S, Parisinos CA, Shallcross L, O’Brien A, Hayward A. Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysis. BMJ Open. 2019;6.
   Google Scholar
• Leise MD, Talwalkar JA. Immunizations in chronic liver disease: what should be done and what is the evidence. Curr Gastroenterol Rep. 2013;15:300. doi:10.1007/s11894-012-0300-6.
   PubMedGoogle Scholar
• Téllez L, Martín Mateos RMCOVID-19. and liver disease: an update. Gastroenterol Hepatol. 2020;43:472–80. doi:10.1016/j.gastrohep.2020.06.006.
   PubMed Web of Science ®Google Scholar
• Smallwood GA, Coloura CT, Martinez E, Stieber AC, Heffron TG. Can patients awaiting liver transplantation elicit an immune response to the hepatitis A vaccine? Transplant Proc. 2002;34:3289–90. doi:10.1016/S0041-1345(02)03572-8.
   PubMed Web of Science ®Google Scholar
• Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, et al. Infectious diseases society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;5(58):309–18. doi:10.1093/cid/cit816.
   Google Scholar
• Gil-Prieto R, Pascual-Garcia R, Walter S, Álvaro-Meca A, Gil-De-Miguel Á. Risk of hospitalization due to pneumococcal disease in adults in Spain. The CORIENNE study. Hum Vaccin Immunother. 2016;2:1900–05.
   Google Scholar
• van Hoek AJ, Andrews N, Waight PA, Stowe J, Gates P, George R, Miller E. The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England. J Infect. 2012;65:17–24. doi:10.1016/j.jinf.2012.02.017.
   PubMed Web of Science ®Google Scholar
• Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, Carlino LO, Owen R, Paterson B, Pelletier L, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med. 2011;8.
   PubMed Web of Science ®Google Scholar
• Härmälä S, Parisinos C, Shallcross L, O’Brien A, Hayward A. Effectiveness of pneumococcal and influenza vaccines to prevent serious health complications in adults with chronic liver disease: a protocol for a systematic review. BMJ Open. 2018;8;e018223.
   PubMed Web of Science ®Google Scholar
• Waghray A, Waghray N, Khallafi H, Menon KV. Vaccinating adult patients with cirrhosis: trends over a decade in the United States. Gastroenterol Res Pract. 2016;2016:5795712.
   Google Scholar
• Dinits-Pensy M, Forrest GN, Cross AS, Hise MK. The use of vaccines in adult patients with renal disease. Am J Kidney Dis. 2005;46(6):997–1011. doi:10.1053/j.ajkd.2005.08.032.
   Web of Science ®Google Scholar
• Pesanti EL. Infections in patients with CRF. Infect Dis Clin North Am. 2001;15:1–15.
   PubMed Web of Science ®Google Scholar
• Grzegorzewska AE. Hepatitis B vaccination in chronic kidney disease patients: a call for novel vaccines. Expert Rev Vaccines. 2014;13:1317–26. doi:10.1586/14760584.2014.944508.
   PubMed Web of Science ®Google Scholar
• European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet. 2000;355:561–65.
   PubMed Web of Science ®Google Scholar
• McGrath LJ, Layton JB, Krueger WS, Kshirsagar AV, Butler AM. High-dose influenza vaccine use among patients receiving hemodialysis in the United States, 2010-2013. Vaccine. 2018;36:6087–94. doi:10.1016/j.vaccine.2018.08.079.
   PubMed Web of Science ®Google Scholar
• Tsujimura K, Ota M, Chinen K, Nagayama K, Oroku M, Shiohira Y, Iseki K, Ishida H, Tanabe K. Effect of influenza vaccine in patients with kidney transplant. Transplant Proc. 2018;50:2443–46. doi:10.1016/j.transproceed.2018.02.186.
   PubMed Web of Science ®Google Scholar
• The renal association. COVID-19 vaccination for adult patients with kidney disease: a position statement from the UK renal community. [accessed 2021 May 4]. https://renal.org/health-professionals/covid-19/ra-resources/covid-19-vaccination-adult-patients-kidney-disease.
   Google Scholar
• Getting the COVID-19 Vaccine. What kidney patients need to know. [accessed 2021 May 4]. https://www.kidney.org/newsletter/getting-covid-19-vaccine-what-kidney-patients-need-to-know.
   Google Scholar
• ERA-EDTA Council; ERACODA Working Group. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant. 2021;36:87–94. doi:10.1093/ndt/gfaa314.
   PubMed Web of Science ®Google Scholar
• Gilbertson DT, Guo H, Arneson TJ, Collins AJ. The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients. Nephrol Dial Transplant. 2011;26:2934–39. doi:10.1093/ndt/gfq853.
   PubMed Web of Science ®Google Scholar
• Mathew R, Mason D, Kennedy JS. Vaccination issues in patients with chronic kidney disease. Expert Rev Vaccines. 2014;13:285–98. doi:10.1586/14760584.2014.874950.
   PubMed Web of Science ®Google Scholar
• Wang IK, Lin CL, Lin PC, Liang CC, Liu YL, Chang CT, Yen TH, Morisky DE, Huang CC, Sung FC. Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study. PLoS One. 2013;8(3):e58317.
   Web of Science ®Google Scholar
• Ishigami J, Sang Y, Grams M, Coresh J, Chang A, Matsushita K. Effectiveness of influenza vaccination among older adults across kidney function: pooled analysis of 2005-2006 through 2014-2015 influenza seasons. Am J Kidney Dis. 2020;75:887–96. doi:10.1053/j.ajkd.2019.09.008.
   PubMed Web of Science ®Google Scholar
• Smith C, Khanna R. Immune regulation of human herpesviruses and its implications for human transplantation. Am J Transplant. 2013;13:9–23. doi:10.1111/ajt.12005.
   PubMed Web of Science ®Google Scholar
• Jones C, Heath P. Antenatal immunization. Hum Vaccin Immunother. 2014;10:2118–22. doi:10.4161/hv.29610.
   PubMed Web of Science ®Google Scholar
• van der Veldt AAM, Oosting SF, Dingemans AC, Fehrmann RSN, GeurtsvanKessel C, Jalving M, Rimmelzwaan GF, Kvistborg P, Blank CU, Smit EF, et al. COVID-19 vaccination: the VOICE for patients with cancer. Nat Med. 2021;27(4):568–569.
   Web of Science ®Google Scholar
• Cordonnier C, Einarsdottir S, Cesaro S, Di Blasi R, Mikulska M, Rieger C, de Lavallade H, Gallo G, Lehrnbecher T, Engelhard D, et al. European conference on infections in Leukaemia group. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis. 2019;19:e200–e212. doi:10.1016/S1473-3099(18)30600-5.
   PubMed Web of Science ®Google Scholar
• British Society of Blood and Marrow Transplantation and Cellular Therapy. BSBMTCT AND COVID. [accessed 2021 May 4]. https://bsbmtct.org/bsbmtct-and-covid/.
   Google Scholar
• Dahyot-Fizelier C, Debaene B, Mimoz O. Gestion du risque infectieux chez le splénectomisé [Management of infection risk in asplenic patients]. Ann Fr Anesth Reanim. 2013;32:251–56. doi:10.1016/j.annfar.2013.01.025.
   PubMedGoogle Scholar
• Salvadori MI, Price VE, Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Preventing and treating infections in children with asplenia or hyposplenia. Paediatr Child Health. 2014;19:271–78. doi:10.1093/pch/19.5.271.
   PubMed Web of Science ®Google Scholar
• Castagnola E, Fioredda F. Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes. Eur J Haematol. 2003;71:319–26. doi:10.1034/j.1600-0609.2003.00158.x.
   PubMed Web of Science ®Google Scholar
• Papp KA, Haraoui B, Kumar D, Marshall J, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, et al. Vaccination guidelines for patients with immune-mediated disorders on immunosuppressive therapies. J Cutan Med Surg. 2019;23:50–74. doi:10.1177/1203475418811335.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. General best practice guidelines for immunization: best practices guidance of the advisory committee on immunization practices (ACIP). [accessed 2021 May 4]. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/immunocompetence.html.
   Google Scholar
• Danziger-Isakov L, Kumar D, Id AST, Community of Practice. Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33. doi:10.1111/ctr.13563.
   Web of Science ®Google Scholar
• Health and Safety Executive HSE. Immunization guidelines chapter 3. [accessed 2021 May 4]. https://www.hse.ie/eng/health/immunisation/hcpinfo/guidelines/.
   Google Scholar
• Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E. COVID-19 and solid organ transplantation: a review article. Transplantation. 2021;105:37–55. doi:10.1097/TP.0000000000003523.
   PubMed Web of Science ®Google Scholar
• Aslam S, Goldstein DR, Vos R, Gelman AE, Kittleson MM, Wolfe C, Danziger-Isakov L. COVID-19 vaccination in our transplant recipients: the time is now. J Heart Lung Transplant. 2021;40(3):169–71. doi:10.1016/j.healun.2020.12.009.
   PubMed Web of Science ®Google Scholar
• Crum-Cianflone NF, Wallace MR. Vaccination in HIV-infected adults. AIDS Patient Care STDS. 2014;28:397–410. doi:10.1089/apc.2014.0121.
   PubMed Web of Science ®Google Scholar
• Ashorobi D, Fernandez R. In: Statpearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. [accessed 2021 May 3]. https://www.ncbi.nlm.nih.gov/books/NBK538171/.
   Google Scholar
• Società Italiana Malattie Infettive. Linee Guida Italiane sull’utilizzo dei farmaci antiretrovirali e sulla gestione diagnostico-clinica delle persone con infezione da HIV-1. [accessed 2021 May 4]. https://www.simit.org/images/documenti/81-lineeguidahiv.pdf.
   Google Scholar
• ESMO Statements for vaccination against COVID-19 in patients with cancer. ESMO Statements for vaccination against COVID-19 in patients with cancer. [accessed 2021 May 4]. https://www.esmo.org/content/download/402887/7815383/1/Covid-19-Vaccinations-and-Patients-with-Cancer-An-ESMO-Call-to-Action.pdf.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012;61:816–19.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 2013;62:521–24.
   PubMed Web of Science ®Google Scholar
• Public Health England. 2013. The green book. Pneumococcal Chapter 25. [accessed 2021 May 4]. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/263318/Green-Book-Chapter-25-v5_2.pdf.
   Google Scholar
• Danziger-Isakov L, Kumar D, Id AST, Community of Practice. Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9):e13563.
   Google Scholar
• Moreno A, Cervera C, Gavaldá J, Rovira M, de la Cámara R, Jarque I, Montejo M, de la Torre-Cisneros J, Miguel Cisneros J, Fortún J, et al. Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain. Am J Transplant. 2007;7:2579–86. doi:10.1111/j.1600-6143.2007.01964.x.
   PubMed Web of Science ®Google Scholar
• Husain S, Chan KM, Palmer SM, Hadjiliadis D, Humar A, McCurry KR, Wagener MM, Singh N. Bacteremia in lung transplant recipients in the current era. Am J Transplant. 2006;6:3000–07. doi:10.1111/j.1600-6143.2006.01565.x.
   PubMed Web of Science ®Google Scholar
• Iida T, Kaido T, Yagi S, Yoshizawa A, Hata K, Mizumoto M, Mori A, Ogura Y, Oike F, Uemoto S. Posttransplant bacteremia in adult living donor liver transplant recipients. Liver Transpl. 2010;16:1379–85. doi:10.1002/lt.22165.
   PubMed Web of Science ®Google Scholar
• Candel FJ, Grima E, Matesanz M, Cervera C, Soto G, Almela M, Martínez JA, Navasa M, Cofán F, Ricart MJ, et al. Bacteremia and septic shock after solid-organ transplantation. Transplant Proc. 2005;37:4097–99. doi:10.1016/j.transproceed.2005.09.181.
   PubMed Web of Science ®Google Scholar
• van Veen KE, Brouwer MC, van der Ende A, van de Beek D. Bacterial meningitis in solid organ transplant recipients: a population-based prospective study. Transpl Infect Dis. 2016;18:674–80. doi:10.1111/tid.12570.
   PubMed Web of Science ®Google Scholar
• Thng ZX, Smet MD, Lee CS, Gupta V, Smith JR, Cluskey PJ, Thorne JE, Kempen JHL, Zierhut M, Nguye QD, et al. COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs. Br J Ophthalmol. 2021;105:306–10. doi:10.1136/bjophthalmol-2020-316586.
   PubMed Web of Science ®Google Scholar
• Alfishawy M, Elbendary A, Mohamed M, Nassar MCOVID-19. Mortality in transplant recipients. Int J Organ Transplant Med. 2020;11:145–62.
   PubMed Web of Science ®Google Scholar
• Petersen EE, Davis NL, Goodman D, Cox S, Mayes N, Johnston E, Syverson C, Seed K, Shapiro-Mendoza CK, Callaghan WM, et al. Vital signs: pregnancy-related deaths, United States, 2011-2015, and strategies for prevention, 13 States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2019;68:423–29.
   PubMed Web of Science ®Google Scholar
• Liang LD, Kotadia N, English L, Kissoon N, Ansermino JM, Kabakyenga J, Lavoie PM, Wiens MO. Predictors of mortality in neonates and infants hospitalized with sepsis or serious infections in developing countries: a systematic review. Front Pediatr. 2018;6:277. doi:10.3389/fped.2018.00277.
   PubMed Web of Science ®Google Scholar
• Maertens K, Orije MRP, Van Damme P, Leuridan E. Vaccination during pregnancy: current and possible future recommendations. Eur J Pediatr. 2020;179:235–42. doi:10.1007/s00431-019-03563-w.
   PubMed Web of Science ®Google Scholar
• Rasmussen SA, Jamieson DJ, Uyeki TM. Effects of influenza on pregnant women and infants. Am J Obstet Gynecol. 2012;207:S3–8. doi:10.1016/j.ajog.2012.06.068.
   PubMed Web of Science ®Google Scholar
• D’Heilly C, Switzer C, Macina D. Safety of maternal immunization against pertussis: a systematic review. Infect Dis Ther. 2019;8:543–68. doi:10.1007/s40121-019-00265-6.
   PubMed Web of Science ®Google Scholar
• Advisory Committee on Immunization Practices Centers for Disease Control and Prevention (CDC). Guiding principles for development of ACIP recommendations for vaccination during pregnancy and breastfeeding. MMWR Morb Mortal Wkly Rep. 2008;57.
   Google Scholar
• Adhikari EH, Spong CY. COVID-19 vaccination in pregnant and lactating women. JAMA. 2021;325:1039–40. doi:10.1001/jama.2021.1658.
   PubMed Web of Science ®Google Scholar
• Silasi M, Cardenas I, Kwon JY, Racicot K, Aldo P, Mor G. Viral infections during pregnancy. Am J Reprod Immunol (New York, N Y 1989). 2015;73:199–213.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. ACOG committee opinion No. 661: integrating immunizations into practice. Obstet Gynecol. 2016;127(4):e104–e107.
   Web of Science ®Google Scholar
• Committee on Obstetric Practice. Immunization and emerging infections expert work group. Committee opinion No. 718: update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Obstet Gynecol. 2017;130(3):e153–e157.
   Web of Science ®Google Scholar
• National Health Service (UK). Vaccination for women who are planning pregnancy, pregnant or breastfeeding [accessed 2021 May 4]. https://immunisationhandbook.health.gov.au/vaccination-for-special-risk-groups/vaccination-for-women-who-are-planning-pregnancy-pregnant-or.
   Google Scholar
• Società Italiana di Ginecologia. Vaccinazioni in Gravidanza proteggila per proteggerli. Vaccinazioni in Gravidanza proteggila per proteggerli – SIGO [accessed 2021 May 4].
   Google Scholar
• Centers for Disease Control and Prevention. Vaccination safety for breastfeeding mothers. [accessed 2021 May 4]. https://www.cdc.gov/breastfeeding/breastfeeding-special-circumstances/vaccinations-medications-drugs/vaccinations.html.
   Google Scholar